NEW YORK, Jan. 28 (GenomeWeb News) - Applied Biosystems reported increased revenues and earnings for its fiscal year 2004 second quarter, along with slightly increased R&D spending.
For the ending Dec. 31, 2003, Applied Biosystems reported revenues of $458.4 million, compared to $444.7 million for the same period a year ago.
Revenues in different product categories were as follows (year-ago revenues in brackets): DNA sequencing $170.4 million ($174.8 million), SDS and other applied genomics $104.3 million ($85.4 million), mass spectrometry $103.4 million ($92.6 million), revenues, core DNA synthesis and PCR $51.3 million ($51.9), other product lines $29 million ($40 million).
The company's net income for the quarter was $52.4 million, or $0.25 per share, compared to $29.2 million, or $0.14 per share, in the prior year quarter.
Applied Biosystems spent $60.7 million for R&D and engineering during the quarter, compared to $59.2 million the year before.